Fulcrum Therapeutics Inc (FULC) Company Profile & Statistics

Fulcrum Therapeutics Inc
FULC
(Nasdaq - US)
Closed
4.79
+0.23 (+5.04%)
in:usd•As of: Nov 29, 2023 15:59 UTC -5
Open
4.69
High
4.88
Low
4.69

About Fulcrum Therapeutics Inc

CEO

Robert J. Gould

Headquarters

26 landsdowne street

cambridge, ma 02139, united states

Auditor

Ernst & Young LLP

Employees

Share Holders

Website

www.fulcrumtx.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

Fulcrum Therapeutics Inc. is a clinical-stage biopharmaceutical company. It is focused on genetically defined diseases with an initial focus on rare diseases. Fulcrum Therapeutics Inc. is based in Cambridge, United States.

Fulcrum Therapeutics Inc Statistics

Valuation Measures

Market Capitalization ²	296.12M
Enterprise Value	266.04M
Enterprise Value/EBITDA (ttm)	-2.45
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	1.17
Price to Sales (ttm)	114.25
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	100.00%
Operating Margin (ttm)	-3769.15%
Profit Margin (ttm)	-4520.47%
Return on Equity (ttm)	-38.48%
Return on Invested Capital (ttm)	-39.54%
Return on Assets (ttm)	-35.04%

Income Statement

Revenue (ttm)	2.62M
Revenue Per Share (ttm)	0.04
Gross Profit (ttm)	2.62M
EBITDA (ttm)³	-108.39M
Net Income Avi to Common (ttm)	-98.71M
Diluted EPS (ttm)	-1.68

Share Statistics

Beta (5Y Monthly)	2.15
52-Week Change	-30.07%
S&P500 52-Week Change	11.53%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	61.82M
Dividend Yield	0.00%
Float ⁴	60.28M
% Held by Insiders	2.50%
% Held by Institutions	89.83%

Balance Sheet

Total Cash (mrq)	257.09M
Total Cash Per Share (mrq)	4.16
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	18.65%
Quick Ratio (mrq)	18.65%
Book Value Per Share (mrq)	4.13

Cash Flow

Operating Cash Flow Per Share (ytd)	-1.10
Free Cash Flow (ytd)	-68.24M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Fulcrum Therapeutics Inc

Trade With A Regulated Broker